ERVs form double-stranded RNA (dsRNA) structures in the cytoplasm, which are then recognized by a pattern recognition receptor, the melanoma differentiation-associated gene 5 (MDA5), followed by activation of an interferon (IFN) immune response in cancer cells including CRC cells [20,21]. This evidence concerns the gene IFIH1 and cancer.